Showing results (31-40 of 293) with videos related to

Sort By:
Pageof 30
Bioinformatics (Oxford, England)|March 26, 2026
CpGene: A Web Application for Epigenetic Signature Identification from DNA Methylation ArraysKonstantinos Lazaros, Souzana Logotheti, Christopher Logothetis, et al.
Molecular Cancer Therapeutics|October 14, 2003
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenograftsSimon Williams, Curtis Pettaway, Rendu Song, et al.
European Urology Oncology|July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node MetastasisAmado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.
The Journal of Urology|March 12, 2003
Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cellsElizabeth M Bruckheimer, Kevin Spurgers, Nancy L Weigel, et al.
Revista Espanola De Enfermedades Digestivas|April 30, 2024
Etiological diagnosis of recurrent acute pancreatitisAlberto Gómez Pérez, Ana Aparicio Serrano, Francisco Javier Serrano Ruiz
Prostate Cancer and Prostatic Diseases|February 11, 2021
Clinical considerations for the management of androgen indifferent prostate cancerJacob E Berchuck, Paul V Viscuse, Himisha Beltran, et al.
Asian Journal of Urology|March 8, 2018
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistanceStyliani Karanika, Theodoros Karantanos, Jianhua Yin, et al.
Histopathology|June 29, 2011
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signallingVassiliki Tzelepi, Maria Karlou, Sijin Wen, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2020
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerArif Hussain, Abhishek Tripathi, Christopher Pieczonka, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate CancerSang T Kim, William A Murphy, Ana Aparicio, et al.
Pageof 30